B Otová

798 total citations
50 papers, 675 citations indexed

About

B Otová is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, B Otová has authored 50 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Immunology. Recurrent topics in B Otová's work include Acute Lymphoblastic Leukemia research (11 papers), T-cell and Retrovirus Studies (9 papers) and Lymphoma Diagnosis and Treatment (6 papers). B Otová is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), T-cell and Retrovirus Studies (9 papers) and Lymphoma Diagnosis and Treatment (6 papers). B Otová collaborates with scholars based in Czechia, Netherlands and Poland. B Otová's co-authors include Ivan Votruba, Antonı́n Holý, Pavel Kramata, Gabriel Birkuš, Jan Trka, Ondřej Krejčí, Markéta Kalinová, Jozef Madžo, Ondřej Hrušák and Soe Thein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer and Journal of Medicinal Chemistry.

In The Last Decade

B Otová

49 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Otová Czechia 12 259 214 201 164 84 50 675
Richard Bazin Canada 15 324 1.3× 183 0.9× 52 0.3× 112 0.7× 202 2.4× 25 1.1k
Carola Berger Germany 13 324 1.3× 208 1.0× 33 0.2× 317 1.9× 41 0.5× 18 901
Jesse K. Mackey United States 15 407 1.6× 145 0.7× 201 1.0× 99 0.6× 10 0.1× 19 675
Suzane Ramos da Silva United States 18 423 1.6× 174 0.8× 368 1.8× 318 1.9× 118 1.4× 30 1.0k
Shari M. Kaiser United States 11 553 2.1× 151 0.7× 289 1.4× 208 1.3× 39 0.5× 26 1.1k
Xiaozhen Liang China 17 212 0.8× 136 0.6× 380 1.9× 411 2.5× 29 0.3× 38 866
Maarit Neuvonen Finland 9 364 1.4× 270 1.3× 146 0.7× 48 0.3× 276 3.3× 10 813
Diane Ilsley United States 9 371 1.4× 57 0.3× 62 0.3× 96 0.6× 19 0.2× 9 570
Assunta Venuti Italy 15 158 0.6× 41 0.2× 79 0.4× 184 1.1× 32 0.4× 37 497
Pauline Chugh United States 14 480 1.9× 184 0.9× 204 1.0× 186 1.1× 48 0.6× 17 911

Countries citing papers authored by B Otová

Since Specialization
Citations

This map shows the geographic impact of B Otová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Otová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Otová more than expected).

Fields of papers citing papers by B Otová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Otová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Otová. The network helps show where B Otová may publish in the future.

Co-authorship network of co-authors of B Otová

This figure shows the co-authorship network connecting the top 25 collaborators of B Otová. A scholar is included among the top collaborators of B Otová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Otová. B Otová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otová, B, Iwao Ojima, Radka Václavíková, et al.. (2011). Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes. Investigational New Drugs. 30(3). 991–1002. 9 indexed citations
2.
Zápotocký, Michal, et al.. (2007). Experimental Therapy with 9-[2-(Phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP): Origin of Resistance. Folia Biologica. 53(3). 79–84. 5 indexed citations
3.
Otová, B, Radka Václavíková, Vlasta Danielová, et al.. (2006). Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague–Dawley/Cub rats. European Journal of Pharmaceutical Sciences. 29(5). 442–450. 11 indexed citations
4.
Votruba, Ivan, et al.. (2005). Inhibition of thymidine phosphorylase (PD-ECGF) from SD-lymphoma by phosphonomethoxyalkyl thymines. Biochemical Pharmacology. 69(10). 1517–1521. 23 indexed citations
5.
Otová, B, V Bı́lá, Ivan Votruba, et al.. (2004). PMEDAP and its N6-substituted derivatives: genotoxic effect and apoptosis in in vitro conditions.. PubMed. 23(6C). 4933–9. 7 indexed citations
6.
Krejčí, Ondřej, Júlia Starková, B Otová, et al.. (2004). Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells. Leukemia. 18(3). 434–441. 43 indexed citations
7.
8.
Madžo, Jozef, Jan Zuna, Kateřina Mužíková, et al.. (2002). Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia. Cancer. 97(1). 105–113. 29 indexed citations
9.
Otová, B, et al.. (2001). DIFFERENT MECHANISMS IN INHIBITION OF RAT MACROPHAGE NITRIC OXIDE SYNTHASE EXPRESSION BY FK 506 AND CYCLOSPORIN A. Immunopharmacology and Immunotoxicology. 23(1). 67–74. 13 indexed citations
10.
Otová, B, et al.. (2000). Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages.. Physiological Research. 49(6). 725–728. 8 indexed citations
11.
Otová, B, et al.. (1999). Characterization of T-cell lymphomas in the Prague inbred Sprague-Dawley/cub rat strain: a model of spontaneous hematologic malignancy. Transplantation Proceedings. 31(3). 1618–1619. 2 indexed citations
12.
Birkuš, Gabriel, Ivan Votruba, Antonı́n Holý, & B Otová. (1999). 9-[2-(phosphonomethoxy)ethyl]adenine diphosphate (PMEApp) as a substrate toward replicative DNA polymerases α, δ, ε, and ε∗. Biochemical Pharmacology. 58(3). 487–492. 21 indexed citations
13.
Bı́lá, V, et al.. (1997). Genetic analysis of graft-versus-host disease using rat recombinant inbred strains. Transplantation Proceedings. 29(3). 1734–1735. 3 indexed citations
14.
Otová, B, et al.. (1997). Inhibition of acute graft-versus-host disease in (LEW.1W × lew.1A)F1 rats using 9-(2-phosphonomethoxyethyl)-2,6-diaminopurine. Transplantation Proceedings. 29(3). 1736–1737. 1 indexed citations
15.
Holubová, J, et al.. (1997). Electron microscopic demonstration of the interaction of liposomes and cells in vitro.. PubMed. 43(4). 161–4. 1 indexed citations
16.
Otová, B, et al.. (1997). Biological characteristics of spontaneous transplantable T-cell lymphomas in inbred Sprague-Dawley/cub rats. Transplantation Proceedings. 29(3). 1754–1755. 4 indexed citations
17.
Kramata, Pavel, Ivan Votruba, B Otová, & Antonı́n Holý. (1996). Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.. Molecular Pharmacology. 49(6). 1005–1011. 102 indexed citations
18.
Zı́dek, Zdeňek, Daniela Franková, & B Otová. (1995). Lack of causal relationship between inducibility/severity of adjuvant arthritis in the rat and disease associated changes in production of nitric oxide by macrophages.. Annals of the Rheumatic Diseases. 54(4). 325–327. 7 indexed citations
19.
Otová, B, et al.. (1993). Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). I. Lymphatic leukemia KHP-Lw-I in Lewis rats.. PubMed. 39(3). 136–41. 7 indexed citations
20.
Otová, B, et al.. (1978). Immunogenetic study of a histocompatibility system in linkage with albino locus from I LG of the Norway rat.. PubMed. 24(6). 378–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Bazin Breakdown of academic impact, for papers by Carola Berger Breakdown of academic impact, for papers by Jesse K. Mackey Breakdown of academic impact, for papers by Suzane Ramos da Silva Breakdown of academic impact, for papers by Shari M. Kaiser Breakdown of academic impact, for papers by Xiaozhen Liang Breakdown of academic impact, for papers by Maarit Neuvonen Breakdown of academic impact, for papers by Diane Ilsley Breakdown of academic impact, for papers by Assunta Venuti Breakdown of academic impact, for papers by Pauline Chugh
Rankless by CCL
2026